Goldman initiated coverage on Dexcom with a new price target
$DXCM
Medical/Dental Instruments
Health Care
Goldman initiated coverage of Dexcom with a rating of Buy and set a new price target of $104.00
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/16/2025 | $102.00 | Buy | Truist |
5/30/2025 | $104.00 | Buy | Goldman |
4/10/2025 | $85.00 | Outperform | Mizuho |
2/3/2025 | $85.00 → $115.00 | Neutral → Buy | Redburn Atlantic |
1/16/2025 | $86.00 → $104.00 | Neutral → Outperform | Robert W. Baird |
7/26/2024 | $161.00 → $80.00 | Outperform → Neutral | Robert W. Baird |
7/26/2024 | $145.00 → $75.00 | Overweight → Neutral | JP Morgan |
5/30/2024 | $130.00 | Neutral | Redburn Atlantic |